REPOCEUTICALS A/S: Financial statements 2025
CVR: 36494433
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
REPOCEUTICALS A/S (CVR 36494433) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. The profit margin was -7,078.3%. Equity in the 2025 report amounted to DKK 6,245,088,000. The solvency ratio was 60.6%.
- Revenue
- DKK 88,000,000
- Gross Profit
- DKK 88,000,000
- Profit/Loss
- DKK -6,228,938,000
- Equity
- DKK 6,245,088,000
- Total Assets
- DKK 10,301,646,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 88M | 88M | -6.2B | 6.2B | - |
| 2024 | 0 | 0 | -6.3M | 4.8M | - |
| 2023 | 0 | 0 | -5.2M | 2.8M | - |
| 2022 | 0 | 0 | -3.8M | 8.3M | - |
| 2021 | 0 | 0 | -4.4M | 12M | - |
Official annual report
How creditworthy is REPOCEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of October 22, 2025, Troels Peter Troelsen has joined the board of directors of REPOCEUTICALS A/S.
As of October 22, 2025, Henrik Bulskov has joined the board of directors of REPOCEUTICALS A/S.
As of October 21, 2025, Troels Peter Troelsen has left the board of directors of REPOCEUTICALS A/S.
As of October 21, 2025, Henrik Bulskov has left the board of directors of REPOCEUTICALS A/S.
As of September 19, 2025, DMZ HOLDING ApS is registered as an owner of REPOCEUTICALS A/S with an ownership share of 15%.
REPOCEUTICALS A/S has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -6,274,548.
As of June 27, 2025, Preben Møllegaard Grundtvig has left the board of directors of REPOCEUTICALS A/S.
As of June 27, 2025, Sigbjørn Georg Nielsen Kjærgård has left the board of directors of REPOCEUTICALS A/S.
About REPOCEUTICALS A/S
REPOCEUTICALS A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named REPOCEUTICALS ApS. The management consists of Torsten Bjørn. The board consists of Henrik Bulskov (chair), Charlotte Pahl and Christian Vinding Thomsen. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and DMZ HOLDING ApS. The company has 2 employees (2026). In 2025, the company reported revenue of DKK 88,000,000 and a net result of DKK -6,228,938,000 compared with DKK -6,274,548 the year before. Equity in the 2025 report amounted to DKK 6,245,088,000.